Machine Learning and Feature Selection Methods for <i>EGFR</i> Mutation Status Prediction in Lung Cancer
The evolution of personalized medicine has changed the therapeutic strategy from classical chemotherapy and radiotherapy to a genetic modification targeted therapy, and although biopsy is the traditional method to genetically characterize lung cancer tumor, it is an invasive and painful procedure fo...
Main Authors: | Joana Morgado, Tania Pereira, Francisco Silva, Cláudia Freitas, Eduardo Negrão, Beatriz Flor de Lima, Miguel Correia da Silva, António J. Madureira, Isabel Ramos, Venceslau Hespanhol, José Luis Costa, António Cunha, Hélder P. Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/11/7/3273 |
Similar Items
-
An Explainable Radiogenomic Framework to Predict Mutational Status of KRAS and EGFR in Lung Adenocarcinoma Patients
by: Berardino Prencipe, et al.
Published: (2023-06-01) -
A Radiogenomics Ensemble to Predict EGFR and KRAS Mutations in NSCLC
by: Silvia Moreno, et al.
Published: (2021-04-01) -
<italic>EGFR</italic> Assessment in Lung Cancer CT Images: Analysis of Local and Holistic Regions of Interest Using Deep Unsupervised Transfer Learning
by: Francisco Silva, et al.
Published: (2021-01-01) -
Prediction of EGFR Mutation Status in Non–Small Cell Lung Cancer Based on Ensemble Learning
by: Youdan Feng, et al.
Published: (2022-06-01) -
Dynamic Evaluation of Circulating miRNA Profile in <i>EGFR</i>-Mutated NSCLC Patients Treated with EGFR-TKIs
by: Alessandro Leonetti, et al.
Published: (2021-06-01)